Related Experiment Video

Updated: Jun 20, 2026

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Stem cell therapy for Parkinson's disease: a road map for a successful future

Román Vidaltamayo1, José Bargas, Luis Covarrubias

  • 1Depto de Neurociencias and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México.

Stem Cells and Development
|September 1, 2009
PubMed

Insights

Cell transplant therapy for Parkinson's disease (PD) shows promise but faces challenges. Research explores stem cell suitability and efficacy evaluation to improve upon current treatments.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Biology

Background:

  • Cell transplant therapy for Parkinson's disease (PD) has been experimental for over 20 years.
  • Current cell therapies face limitations in cell source availability and therapeutic value compared to pharmacological options.
  • Various cell types are being investigated as potential alternatives for PD treatment.

Purpose of the Study:

  • To discuss the suitability of different stem cell types for Parkinson's disease therapy.
  • To outline the requirements for donor cells to enhance current therapeutic methods.
  • To propose alternative approaches for evaluating the efficacy of cell-based therapies for PD.

Main Methods:

  • Review of existing literature on cell transplant therapies for Parkinson's disease.
  • Analysis of stem cell types and their potential therapeutic applications in PD.
  • Discussion of criteria for donor cell selection and efficacy assessment.

Main Results:

  • Stem cell suitability for PD therapy is under investigation, with specific requirements for donor cells identified.
  • Current cell transplant methods for PD are limited by cell source and comparative efficacy.
  • Alternative strategies for evaluating cell therapy efficacy in PD are proposed.

Conclusions:

  • Optimizing stem cell selection and evaluation methods is crucial for advancing Parkinson's disease cell therapy.
  • Addressing donor cell requirements and efficacy assessment will be key to improving upon existing treatments.
  • Further research is needed to establish reliable and effective cell transplant strategies for PD.

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...